Wed, January 15, 2025
Tue, January 14, 2025
Mon, January 13, 2025
Sun, January 12, 2025
Sat, January 11, 2025
Fri, January 10, 2025
Thu, January 9, 2025
[ Thu, Jan 09th ] - Kiplinger
The Best Bank ETFs to Buy
Wed, January 8, 2025
Tue, January 7, 2025
Mon, January 6, 2025
Sun, January 5, 2025
Sat, January 4, 2025
Fri, January 3, 2025
[ Fri, Jan 03rd ] - MSN
3 Vanguard ETFs to Buy in 2025
[ Fri, Jan 03rd ] - MSN
How Money Can Make More Money
Thu, January 2, 2025
Wed, January 1, 2025
Tue, December 31, 2024

This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly


//stocks-investing.news-articles.net/content/202 .. -opportunity-for-novo-nordisk-and-eli-lilly.html
Published in Stocks and Investing on Wednesday, January 8th 2025 at 14:01 GMT by MSN   Print publication without navigation

  • Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due to their successful diabetes and weight loss medications. They are also big players in the burgeoning GLP-1 weight loss market,

The article discusses a promising new study on Alzheimer's disease that could significantly impact the pharmaceutical companies Novo Nordisk and Eli Lilly. Researchers have found that a new class of drugs, which target insulin resistance in the brain, could potentially slow or even reverse Alzheimer's progression. This development is particularly exciting because it opens up a new avenue for treatment beyond the amyloid-beta plaques traditionally targeted. Both Novo Nordisk and Eli Lilly, already leaders in diabetes treatment with their insulin-related products, are well-positioned to capitalize on this research due to their expertise in insulin therapies. The study's success could lead to these companies expanding into the Alzheimer's treatment market, potentially unlocking massive growth opportunities as they leverage their existing research and development capabilities in insulin-related treatments.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/this-promising-new-alzheimer-s-study-could-unlock-a-massive-growth-opportunity-for-novo-nordisk-and-eli-lilly/ar-AA1xbrOK ]

Publication Contributing Sources